VALIANT® Captivia VAMC4040C150TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMC4040C150TU VALCAP CLOSE · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00643169346833), received between Jun 21, 2017 and Jun 24, 2025 — classified as 6 injuries, 1 malfunction.
The most frequently reported specific device problem is “Leak/Splash” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Leak/Splash5
- Adverse Event Without Identified Device or Use Problem2
- Migration or Expulsion of Device1
Patient problems
- Injury2
- Aneurysm expansion1
- Dyspnea1
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
- Pain1
- Perforation1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryJun 24, 2025Leak/Splash; Leak/Splash
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED DURING AN ENDOVASCULAR PROCEDURE. IT WAS REPORTED THAT 2 WEEKS LATER INTERVENTION WAS PERFORMED WHERE ARCH VESSEL REVASCULARIZATION DUE TO ASCENDING AORTIC ANEURYSM . GRAFT EXTENSION WAS CARRIED OUT USING NON-MEDTRONIC DEVICES THE PATIENT WAS HOSPITALISED A MONTH LATER. THE PATIENT HAD LEUKOCYTOSIS AND A CT SUGGESTED POTENTIAL ENDOLEAKS AT MODULAR ATTACHMENT SITES. NO INTERVENTION WAS PERFORMED DUE TO PREVIOUS RAPID DEGENERATION. INFECTION IS NOT SUSPECTED REGARDING THE DEVICE OR PROCEDURE. PATIENT DID HAVE PNEUMONIA WHICH DOES NOT SEEM RELATED. PATIENT STATUS IS ¿NOT RECOVERED/NOT RESOLVED¿. THE SITE, SPONSOR AND INVESTIGATOR ASSESSED THE EVENT AS POSSIBLY RELATED TO THE INDEX PROCEDURE AND NOT RELATED TO THE DEVICE.
Patient problems: Aneurysm expansion
MAUDE report 22317864 ↗InjuryApr 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. TWO 12 FRENCH SHEATHS WERE UTILIZED DURING THE INDEX PROCEDURE. THE PATIENT UNDERWENT TEVAR FOR THE CHRONIC TYPE A DISSECTION WITH ANEURYSMAL DEGENERATION OPERATION AFTER 2ND AAA, BUT THIS DID NOT SEAL OFF ALL THE FENESTRATIONS WITH THE ARCH VESSELS. THE PATIENT WAS OFFERED AN ENDOVASCULAR OFF-LABEL AORTIC ARCH REPAIR. THE HIGH-RISK SURGERY WAS COMPLETE WITH NO EVIDENCE OF AN ENDOLEAK. THE PATIENT RECOVERED APPROX. 20 DAYS POST INDEX PROCEDURE. THE SITE ASSESSED THE TYPE A AORTIC DISSECTION AS HAVING NO RELATIONSHIP TO THE STUDY DEVICE AND NOT RELATED TO THE INDEX PROCEDURE. THE SPONSOR ASSESSED THE TYPE A AORTIC DISSECTION AS POSSIBLE RELATED TO PROCEDURE, NOT RELATED TO DEVICE.
Patient problems: Vascular Dissection
MAUDE report 21909497 ↗InjuryDec 14, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
VALIANT CAPTIVIA STENT GRAFTS WERE INTENDED TO BE IMPLANTED DURING AN ENDOVASCULAR PROCEDURE FOR THE TREATMENT OF A 40MM THORACIC AORTIC ANEURYSM.. IT WAS REPORTED DURING THE INDEX PROCEDURE WHEN THE IMPLANTING VAM4040C150TU THE PHYSICIAN WAS ADVANCING THE DELIVERY SYSTEM WHEN THE WIRE RETRACTED AND THE RIGHT ILIAC ARTERY RUPTURED AND THE STENT WENT THROUGH THE WALL OF THE COMMON ILIAC ARTERY. THE CASE WAS RESOLVED WITH IMPLANTATION OF COVERED ILIAC STENTS. AS PER THE PHYSICIAN THE CAUSE OF THIS EVENT WAS DUE TO THE PATIENTS OWN ANATOMY DUE TO TORTUOUS ILIACS. NO ADDITIONAL CLINICAL SEQUELAE WAS PROVIDED AND THE PATIENT IS FINE.
Patient problems: Perforation; Perforation of Vessels
MAUDE report 13001553 ↗InjuryMay 11, 2021Leak/Splash; Migration or Expulsion of Device; Leak/Splash; Migration or Expulsion of Device
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN AN UNKNOWN ENDOVASCULAR PROCEDURE. APPROXIMATELY 15 MONTHS POST INDEX PROCEDURE, AN ENDOLEAK TYPE 1A WAS NOTED. NO CAUSE OF THE EVENT WAS REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 11806355 ↗InjuryAug 6, 2019Leak/Splash; Leak/Splash
A VALIANT MONA LSA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 72 MM THORACIC AORTIC ANEURYSM . A VALIANT CAPTIVIA STENT GRAFT WAS ALSO IMPLANTED DISTALLY AND OVERLAPPING WITH THE VALIANT MONA LSA DURING THE PROCEDURE. IT WAS REPORTED THAT SOME ANEURYSM GROWTH WAS OBSERVED BY THE SITE THREE YEARS LATER. IT WAS REPORTED THAT A TYPE IA AND TYPE IB ENDOLEAK WAS NOTED BY THE SITE ON (B)(6) 2018 WITH ENLARGEMENT OF THE DISTAL END OF THE COMMERCIAL VALIANT STENT GRAFT OBSERVED TO BE RESULTING IN LOSS OF SEAL AND THE TYPE IB ENDOLEAK. IT WAS REPORTED THAT A YEAR LATER THE PATIENT PRESENTED EMERGENTLY WITH ACUTE ONSET ABDOMINAL PAIN. THE SOURCE OF THE PAIN COULD NOT BE IDENTIFIED. THE PATIENT WAS ADMITTED AND EXPERIENCED SOME CHEST PAIN AND SHORTNESS OF BREATH. THE SOURCE OF THESE COMPLAINTS COULD ALSO NOT BE IDENTIFIED. THE EVENT WAS REPORTED BY THE SPONSOR TO BE POSSIBLY DEVICE RELATED AND BY THE INVESTIGATOR TO NOT BE RELATED TO DEVICE OR PROCEDURE. A SECONDARY PROCEDURE WAS CARRIED OUT ONE WEEK LATER TO REPAIR ANEURYSM EXPANSION WITH THE ADDITION OF A VALIANT STENT GRAFT DISTALLY AND OTHER NON MDT STENT IN THE SMA AND RENAL ARTERIES. THIS INTERVENT
Patient problems: Dyspnea; Injury; Pain
MAUDE report 8863753 ↗InjuryDec 19, 2017Leak/Splash; Leak/Splash
A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 80MM DIAMETER THORACIC AORTIC ANEURYSM. IT WAS REPORTED THAT ON FOLLOW UP CT PERFORMED THERE WAS SUSPICION OF TYPE 1B OR TYPE II ENDOLEAK. A DISTAL EXTENSION(40X40X150) WAS IMPLANTED. IT WAS REPORTED THAT THE PATIENT SUSTAINED A FALL AND A CT WAS PERFORMED. AN INCIDENTAL FINDING ON THE CT PERFORMED, REVEALED THE TYPE IB AND/OR A TYPE II ENDOLEAK HAD NOT RESOLVED. THE PHYSICIAN PLANNED TO EXTEND FARTHER DISTALLY TO THE CELIAC ARTERY. A 40X40X100MM VALIANT STENT GRAFT WAS IMPLANTED SUCCESSFULLY WITH SATISFACTORY RESULTS AND THE EVENT WAS RESOLVED. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS DUE TO TORTUOUS DISTAL AORTA ANATOMY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.
Patient problems: Injury
MAUDE report 7127928 ↗MalfunctionJun 21, 2017Leak/Splash; Leak/Splash
A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 75MM DIAMETER THORACIC AORTIC ANEURYSM. THE DISTAL NECK IS 20MM IN LENGTH AND IT IS 36MM, 29MM, 36MM IN DIAMETER FROM PROXIMAL TO DISTAL, IRREGULAR SHAPED. IT WAS REPORTED THAT AFTER REVIEW OF THE FOLLOW-UP CT IT WAS DETERMINED THAT THE PATIENT MOST LIKELY HAS A DISTAL TYPE I ENDOLEAK. THE PATIENT HAS NOT AND WILL NOT RECEIVE TREATMENT. THE PHYSICIAN STATED THAT THE CAUSE OF THE EVENT WAS ANATOMY RELATED, SHORT DISTAL SEAL ZONE. NO CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED BY THEIR PHYSICIAN.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6659144 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page